KEGG   DISEASE: 家族性アミロイド症
エントリ  
H00845                                                             
名称    
家族性アミロイド症
  下位グループ
遺伝性全身性アミロイドーシス (AMYLD)
アミロイド症フィンランド型 [DS:H02322]
概要    
The amyloidoses are a group of diseases in which proteins that are normally soluble deposit extracellularly in tissues as insoluble fibrils. The fibrils have a characteristic beta-pleated sheet configuration that renders them avid for Congo red dye. In the familial amyloidoses, a gene mutation inherited in an autosomal-dominant manner results in a single amino acid substitution that renders a plasma protein amyloidogenic. Mutations in the TTR gene are the most common cause of familial amyloidosis. The clinical features of familial amyloidosis vary depending on the underlying amyloidogenic protein and the particular amino acid affected by the mutation, ranging from peripheral and autonomic neuropathy to cardiomyopathy.
カテゴリ  
神経系疾患
階層分類  
ICD-11 による疾患分類 [BR:jp08403]
 05 内分泌, 栄養, 代謝の疾患
  代謝疾患
   その他の代謝疾患
    5D00  アミロイドーシス
     H00845  家族性アミロイド症
パスウェイに基づく疾患分類 [BR:jp08402]
 免疫系
  nt06514  凝固カスケード
   H00845  家族性アミロイド症
指定難病 [jp08407.html]
 H00845
ネットワーク
nt06514 Coagulation cascade
病因遺伝子 
(AMYLD1) TTR [HSA:7276] [KO:K20731]
(AMYLD2) FGA [HSA:2243] [KO:K03903]
(AMYLD3) APOA1 [HSA:335] [KO:K08757]
(AMYLD5) LYZ [HSA:4069] [KO:K13915]
(AMYLD6) B2M [HSA:567] [KO:K08055]
治療薬   
ドロキシドパ [DR:D01277]
タファミジスメグルミン [DR:D09674]
パチシランナトリウム [DR:D10794]
ブトリシランナトリウム [DR:D11916]
アコラミジス塩酸塩 [DR:D11973]
タファミジス [DR:D09673]
リンク   
ICD-11: 5D00.2
MeSH: D028226
OMIM: 105210 105200 620657 620658 620659
文献    
  著者
Dember LM
  タイトル
Emerging treatment approaches for the systemic amyloidoses.
  雑誌
Kidney Int 68:1377-90 (2005)
DOI:10.1111/j.1523-1755.2005.00535.x
文献    
  著者
Ando Y, Nakamura M, Araki S
  タイトル
Transthyretin-related familial amyloidotic polyneuropathy.
  雑誌
Arch Neurol 62:1057-62 (2005)
DOI:10.1001/archneur.62.7.1057
文献    
PMID:8097946 (AMYLD2)
  著者
Benson MD, Liepnieks J, Uemichi T, Wheeler G, Correa R
  タイトル
Hereditary renal amyloidosis associated with a mutant fibrinogen alpha-chain.
  雑誌
Nat Genet 3:252-5 (1993)
DOI:10.1038/ng0393-252
文献    
PMID:9931341 (AMYLD3)
  著者
Yamakawa-Kobayashi K, Yanagi H, Fukayama H, Hirano C, Shimakura Y, Yamamoto N, Arinami T, Tsuchiya S, Hamaguchi H
  タイトル
Frequent occurrence of hypoalphalipoproteinemia due to mutant apolipoprotein A-I gene in the population: a population-based survey.
  雑誌
Hum Mol Genet 8:331-6 (1999)
DOI:10.1093/hmg/8.2.331
文献    
PMID:8464497 (AMYLD5)
  著者
Pepys MB, Hawkins PN, Booth DR, Vigushin DM, Tennent GA, Soutar AK, Totty N, Nguyen O, Blake CC, Terry CJ, et al.
  タイトル
Human lysozyme gene mutations cause hereditary systemic amyloidosis.
  雑誌
Nature 362:553-7 (1993)
DOI:10.1038/362553a0
文献    
PMID:22693999 (AMYLD6)
  著者
Valleix S, Gillmore JD, Bridoux F, Mangione PP, Dogan A, Nedelec B, Boimard M, Touchard G, Goujon JM, Lacombe C, Lozeron P, Adams D, Lacroix C, Maisonobe T, Plante-Bordeneuve V, Vrana JA, Theis JD, Giorgetti S, Porcari R, Ricagno S, Bolognesi M, Stoppini M, Delpech M, Pepys MB, Hawkins PN, Bellotti V
  タイトル
Hereditary systemic amyloidosis due to Asp76Asn variant beta2-microglobulin.
  雑誌
N Engl J Med 366:2276-83 (2012)
DOI:10.1056/NEJMoa1201356
LinkDB    

» English version

DBGET integrated database retrieval system